So-mi Kang

Busan, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Author Correction: Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome.

Author Correction: Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome.

Journal: Communications biology

Published: June 27, 2026

Emerging Molecular Insights and Therapeutic Directions in Neurofibromatosis Type 1 and NF2-Related Schwannomatosis.

Emerging Molecular Insights and Therapeutic Directions in Neurofibromatosis Type 1 and NF2-Related Schwannomatosis.

Journal: International journal of molecular sciences

Published: January 09, 2026

Progerin expression in humans: Implications for natural ageing.

Progerin expression in humans: Implications for natural ageing.

Journal: Mechanisms of ageing and development

Published: December 09, 2025

Inhibition of SOD1 trimerization is a novel drug target for ALS disease.

Inhibition of SOD1 trimerization is a novel drug target for ALS disease.

Journal: Translational neurodegeneration

Published: November 11, 2024

The therapeutic effect of DX2 inhibition in nicotine-induced lung cancer progression.

The therapeutic effect of DX2 inhibition in nicotine-induced lung cancer progression.

Journal: Molecular therapy. Oncology

Published: June 03, 2024

NF2-Related Schwannomatosis (NF2): Molecular Insights and Therapeutic Avenues.

NF2-Related Schwannomatosis (NF2): Molecular Insights and Therapeutic Avenues.

Journal: International journal of molecular sciences

Published: May 04, 2024

Progerin, an Aberrant Spliced Form of Lamin A, Is a Potential Therapeutic Target for HGPS.

Progerin, an Aberrant Spliced Form of Lamin A, Is a Potential Therapeutic Target for HGPS.

Journal: Cells

Published: August 08, 2023

Progerinin, an Inhibitor of Progerin, Alleviates Cardiac Abnormalities in a Model Mouse of Hutchinson-Gilford Progeria Syndrome.

Progerinin, an Inhibitor of Progerin, Alleviates Cardiac Abnormalities in a Model Mouse of Hutchinson-Gilford Progeria Syndrome.

Journal: Cells

Published: March 09, 2023

Structural basis for the interaction between unfarnesylated progerin and the Ig-like domain of lamin A/C in premature aging disorders.

Structural basis for the interaction between unfarnesylated progerin and the Ig-like domain of lamin A/C in premature aging disorders.

Journal: Biochemical and biophysical research communications

Published: October 10, 2022

Cyclin-dependent kinase 1 depolymerizes nuclear lamin filaments by disrupting the head-to-tail interaction of the lamin central rod domain.

Cyclin-dependent kinase 1 depolymerizes nuclear lamin filaments by disrupting the head-to-tail interaction of the lamin central rod domain.

Journal: The Journal of biological chemistry

Published: March 02, 2022

Splicing Variants, Protein-Protein Interactions, and Drug Targeting in Hutchinson-Gilford Progeria Syndrome and Small Cell Lung Cancer.

Splicing Variants, Protein-Protein Interactions, and Drug Targeting in Hutchinson-Gilford Progeria Syndrome and Small Cell Lung Cancer.

Journal: Genes

Published: December 11, 2021

Author Correction: Human WRN is an intrinsic inhibitor of progerin, abnormal splicing product of lamin A.

Author Correction: Human WRN is an intrinsic inhibitor of progerin, abnormal splicing product of lamin A.

Journal: Scientific reports

Published: September 02, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026